Table 4.

Average reimbursement charge, and drug cost and laboratory test cost savings by type of patient for period 2 compared to period 1^a.

	Patients with influenza and/or RSV		Patients without influenza and RSV		All patients
	Savings [95% CI]	P-value	Savings [95% CI]	P-value	Savings [95% CI]	P-value
Reimbursement for total admission (£)	50 [-204, 304]	0.70	165 [-2, 332]	0.05	134 [4, 265]	0.04
Reimbursement for stay on the acute pediatric ward (£)	74 [-162, 311]	0.53	148 [1, 295]	0.05	126 [10, 242]	0.03
Cost of drugs (£)	-12b [-21, -3]	<0.01	0 [-11, 10]	0.94	-3 [-11, 5]	0.47
Modeled costs of lab tests (£) (with assumed POCT cost of £30)	105 [93, 117]	<0.01	13 [1, 24]	0.03	44 [34, 53]	<0.01

^aControlling for age, sex, having at least one relevant condition, having a complication, and requiring hospitalization in the high-dependency unit.

^bNegative savings imply an additional cost in the second period with regard to the first period.